XINVABRI

Serial Number 98457633
606

Registration Progress

Application Filed
Mar 19, 2024
Under Examination
Dec 10, 2024
Approved for Publication
Oct 29, 2024
Published for Opposition
Oct 29, 2024
Registered

Trademark Image

XINVABRI

Basic Information

Serial Number
98457633
Filing Date
March 19, 2024
Published for Opposition
October 29, 2024
Abandonment Date
July 14, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jul 14, 2025
Classes
005

Rights Holder

Pfizer Inc.

03
Address
66 Hudson Boulevard East
New York, NY 10001-2192

Ownership History

Pfizer Inc.

Original Applicant
03
New York, NY

Pfizer Inc.

Owner at Publication
03
New York, NY

Legal Representation

Attorney
Richard A. Friedman

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

10 events
Date Code Type Description Documents
Jul 14, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jul 14, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Dec 10, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 29, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 29, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 9, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 19, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 19, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 14, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 20, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; Pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations, and smoking cessation preparations; Vaccines for human use

Classification

International Classes
005